Shriners Hospitals for Children's Dr. Michael Whyte Presents First Efficacy and Safety Results of Targeted Enzyme Replacement Therapy in Patients With Rare Genetic Bone DiseaseJune 11, 2009 | EnobiaAgainst All Odds, The tale of Amy Tinsley, the Belfast baby who became the first infant in the world to undergo a new drug treatment for a fatal genetic disorderJune 01, 2009 | Wave MagazineWinnipeg Regional Health Authority Announces baby Amy homeward-bound following five months on life saving experimental treatment at children’s hospitalMarch 06, 2009 | Enobia
News archive: 2010 | 2009 | 2008 | View AllEnobia in the news |
 |
Help us learn more about what it’s like to live with HPP.
> Click here to participate in a survey
Clinical Trials
Hypophosphatasia: Learn more about Enobia’s clinical trialsStay Informed
 |
 |
 |
 |